HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company's product offerings include the HeartFlow Analysis, which consists of various analyses like FFRCT, RoadMap, and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries including the US, UK, Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning and patient safety. The goal of HeartFlow is to improve cardiovascular care by providing advanced diagnostic tools that facilitate better treatment decisions.